Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy Kymriah
Muhammad Zaheer Abbas (Queensland University), Strategic Use of Patent Opposition Safeguard to Improve Equitable Access to Innovative Health Technologies: A Case Study of CAR T-Cell Therapy Kymriah (2023): Kymriah is an innovative cancer therapy which works by removing disease fighting... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - September 2, 2023 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
The story a cancer survivor and his bond with Lucky the Duck
There is no news that one can hear about oneself that is more dreadful than being told that you have cancer. The mind shuts down for a few minutes. No matter what the doctor is saying, the words do not register. It is like in the movies. The only difference is that the scene passes
Read more…
The story a cancer survivor and his bond with Lucky the Duck originally appeared in KevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - September 1, 2023 Category: General Medicine Authors: Farhan S. Imran, MD Tags: Physician Oncology/Hematology Source Type: blogs
Preventative Health and Longevity Company, Viome Life Sciences, Closes $86.5M Oversubscribed Series C Funding Round
Additional Financing Supports the Further Development of its Suite of Advanced Personalized Health Tests and Expansion into Key Nationwide Retailers such as CVS
Viome Life Sciences, a longevity company committed to translating scientific advancements into practical and individualized health solutions, today announced the successful closure of its $86.5 million oversubscribed Series C funding round. Lead investors include Khosla Ventures and Bold Capital with participation from other existing ones as well as new ones. The raise brings Viome’s total to $175 million and will be used to support research and development and r...
Source: EMR and HIPAA - August 31, 2023 Category: Information Technology Authors: Healthcare IT News Tags: Health IT Company Healthcare IT Bold Capital CVS Gut Intelligence Test Health IT Funding Health IT Fundings Health IT Investment Khosla Ventures Naveen Jain Robbie Schwietzer Viome Viome Life Sciences Source Type: blogs
Transferring the Naked Mole Rat Hyaluronan Synthase 2 Gene Into Mice Reduces Cancer Incidence, Extends Life
Naked mole rats live far longer than similarly sized mammals, and are near immune to cancer. One of the mechanisms of cancer resistance involves the production of a different form of high molecular weight hyaluronan, and much more of it, improving the anti-cancer mechanism of contact inhibition. In addition, other mechanisms derived from changes in hyaluronan may affect life span through improved cellular function, but this is less well explored. Researchers here take the naked mole-rat version of the gene for high molecular weight hyoluronan, hyaluronan synthase 2, and put it into mice. The result is less cancer, improved...
Source: Fight Aging! - August 31, 2023 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Bridging the Representation Gap in Biomedical Research
“We hope that students come out of our program feeling like they’re part of a community. Many of us feel inadequate or struggle in some way during graduate school—it can be a challenging time. I want to build a community that our students can always come back to for support,” says Elana Ehrlich, Ph.D., the co-director of the Bridges to the Doctorate Research Training Program (B2D) at Towson University in Towson, Maryland, alongside Michelle Snyder, Ph.D..
The Towson B2D is one of several NIGMS-supported B2Ds, which are dedicated to developing a diverse pool of well-trained biomedical scientists who will transiti...
Source: Biomedical Beat Blog - National Institute of General Medical Sciences - August 30, 2023 Category: Research Authors: Chrissa Chverchko Tags: Being a Scientist Training Source Type: blogs
